Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Untamed life Safe-havens All over the Planet Offering Remarkable Creature Experiences - 2Make your choice for the bird that catches your heart!
- 3Web designers for Independent ventures
- 4Interoceanic Train derails in southern Mexico, injuring at least 15 and halting traffic on line
- 5Figure out How to Upgrade Your Gold Speculation Portfolio: Vital Bits of knowledge and Strategies
- Step by step instructions to Pick the Right Web-based Degree Program
- West Antarctica’s history of rapid melting foretells sudden shifts in continent’s ‘catastrophic’ geology
- French lawmakers narrowly approve health care budget, suspending Macron's flagship pension reform
- Minnesota jury says Johnson & Johnson owes $65.5 million to woman with cancer who used talcum powder
- Weather forecast, Turkana style: A goat's intestines tell it all
- Surf Spot Mechanics: Bells Beach
- What to know as New York City nurses strike for a 3rd day
- Robyn returns to music with 'Dopamine,' her 1st single in 7 years: 'Came to save music once again'
- Top 15 Web-based Entertainment Stages for Individual Marking
